ARBUTUS BIOPHARMA CORP
ABUSNASDAQ🏆 #2325 by market capEarnings Nov 11US Equity
$4.55▼ $0.12 (−2.68%)
Live1h▼ 0.1%
24h▼ 2.7%
7d▼ 1.4%
14d▲ 6.2%
30d▼ 2.6%
1y▲ 34.1%
🏦Market Cap
$898M
Small Cap
📈Revenue Growth (YoY)
+2889.9%
High Growth
📊Gross Margin
—
💵FCF Margin
10.7%
Healthy
⚖️P/S Ratio
4.7x
Fair
Otter Score
62
Fair
Earnings
Q2 · 2026Reported 2026-05-13Earnings Per Share
Actual
0.87
Expected
-0.03
beat
+3000.00%
YoY +769.20%
Revenue
Actual
$179.13M
Expected
$750.00K
beat
+23783.50%
YoY +10054.50%
Consensus estimates
Recent quarters
Q2 2026
0.87
beat
Q1 2026
-0.01
beat
Q4 2025
-0.04
beat
Q3 2025
0.01
beat